Yuan et al. found that USP10 directly bounds to and stabilized Smad4, promoting HCC metastasis, using a functional RNA-interference screening method; thus, USP10 is considered a prognostic and therapeutic target in Smad4-positive HCC metastatic patients [46]. Here, SMAD4 is linked to hepatocellular carcinoma.